Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, follow...
Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by sequential PPSV23 vaccination in healthy adults aged ≥50 years: A randomized phase III trial (PNEU-PATH)
About this item
Full title
Author / Creator
on behalf of the V114-016 (PNEU-PATH) study group , V114-016 (PNEU-PATH) study group , Song, Joon-Young , Chang, Chih-Jen , Andrews, Charles , Diez-Domingo, Javier , Oh, Myoung-don , Dagan, Ron , Hartzel, Jonathan , Pedley, Alison , Li, Jianing , Sterling, Tina , Tamms, Gretchen , Chiarappa, Joseph A , Lutkiewicz, Jeannine , Musey, Luwy , Tu, Yingmei and Buchwald, Ulrike K
Publisher
Netherlands: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Netherlands: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
AbstractBackgroundStreptococcus pneumoniae causes pneumococcal disease, and older adults are at an increased risk. Sequential vaccination of 13-valent pneumococcal conjugate vaccine (PCV13) followed by 23-valent pneumococcal polysaccharide vaccine (PPSV23) is recommended for broad protection against pneumococcal disease in some countries. MethodsTh...
Alternative Titles
Full title
Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by sequential PPSV23 vaccination in healthy adults aged ≥50 years: A randomized phase III trial (PNEU-PATH)
Authors, Artists and Contributors
Author / Creator
V114-016 (PNEU-PATH) study group
Song, Joon-Young
Chang, Chih-Jen
Andrews, Charles
Diez-Domingo, Javier
Oh, Myoung-don
Dagan, Ron
Hartzel, Jonathan
Pedley, Alison
Li, Jianing
Sterling, Tina
Tamms, Gretchen
Chiarappa, Joseph A
Lutkiewicz, Jeannine
Musey, Luwy
Tu, Yingmei
Buchwald, Ulrike K
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2570110083
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2570110083
Other Identifiers
ISSN
0264-410X
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2021.08.038
